ABSTRACT Feed intake is typically restricted (R) in broiler hens to avoid obesity and improve egg production and livability. To determine whether improved heart health contributes to improved livability, fully adult 45-week-old R hens were allowed to consume feed to appetite (ad libitum; AL) up to 10 wk (70 d). Mortality, contractile functions, and morphology at 70 d, and measurements of cardiac hypertrophic remodeling at 7 d and 21 d were made and compared between R and AL hens. Outcomes for cardiac electrophysiology and mortality, reported separately, found increased mortality in AL hens in association with cardiac pathological hypertrophy and contractile dysfunction. The present study aimed to delineate metabolic cardiomyopathies underlying the etiology of obesity-associated cardiac pathology. Metabolic measurements were made in hens continued on R rations or assigned to AL feeding after 7 d and 21 days. AL feeding increased plasma insulin, glucose, and non-esterified fatty acid (NEFA) concentrations by 21 d (P < 0.05). Metabolic cardiomyopathy in AL-hens was confirmed by cardiac triacylglycerol (TG) and ceramide accumulation consistent with upregulation of related enzyme gene expressions, and by increased indices of oxidation stress (P < 0.05). In contrast to R hens, cardiac pyruvate dehydrogenase (PDH) activity and glucose transporter (GLUT) gene expressions increased progressively while carnitine palmitoyltransferase-1 (CPT-1) transcript levels in AL hens declined from 7 d to 21 d (P < 0.05), reflecting a shift from an oxidative to a more glycolytic metabolism, a typical metabolic derangement associated with cardiac hypertrophic remodeling. Cardiac pathogenesis in AL hens was further indicated by increased leukocyte infiltrates, interleukin-1β (IL-1β) and IL-6 production, cellular apoptosis, interstitial fibrosis, and expression of the heart failure marker myosin heavy chain (MHC-β; cardiac muscle beta) (P < 0.05). Results support the conclusion that diabetic conditions, cardiac inflammation and lipotoxic metabolic derangements act as pathological cues to trigger pathogenic changes along cardiac hypertrophy in AL hens.
INTRODUCTION
Past studies investigated mortality of rapidly growing broilers, in which cardiac and pulmonary growth is inadequate to support muscular growth, namely ascites (Griffin and Goddard, 1994; Julian, 2000; 4 These authors contributed equally to this work. All authors listed have contributed to the work and have agreed to submit the manuscript to Poultry Science. No part of the work has been published before, except in abstract form, and all human and animal studies have been reviewed by the appropriate ethics committees. Wideman et al., 2013) . Few studies have examined premature mortality in adult broiler breeders where concern exists with welfare issues regarding feed restriction to encourage egg production vs. chronic hunger that accompanies this management practice. Our previous works have shown that predictable detrimental metabolic changes (Unger, 2002) accompany lifting of feed restriction that in the short term results in reduced egg production and settable eggs (Chen et al., 2006; Pan et al., 2012; Xie et al., 2012; Liu et al., 2014 Liu et al., , 2016 Walzem and Chen 2014) .
In mammals it is known that obesity and related metabolic disturbances can compromise heart function (Palomer et al., 2013) . We hypothesized that dysfunctions could occur in the hearts of broiler hens under ad libitum (AL) feeding. A separate manuscript with results from the same hen flock documents structural, physiological, and electrophysiological changes in 2438 heart function that accompany obesity development in broiler hens. Cardiac pathological changes occur relatively quickly as fully mature 45-week-old broiler hens exhibit hypertrophic remodeling as evidenced by increased nitric oxide production, calcineurin, and mitogen-activated protein kinase (MAPK) activation in conjunction with up-regulation of heart failure markers, brain natriuretic peptide (BNP) and MHC-β in as little as 21 days. Broiler hens allowed AL feeding for 10 wk had increased mortality rate in association with ascites, pericardial effusion, and ventricle dilation and fibrosis. The occurrence of persistently elevated systolic blood pressure and irregular electrocardiography (ECG) patterns and rhythmicity in AL hens suggested that systemic derangements drive cardiac pathological hypertrophy leading to overt pathogenesis in contractility. AL hens exhibited suppressed 5' AMP-activated protein kinase (AMPK) activation, a crucial cellular fuel sensor in the regulation of glucose uptake and production, β-oxidation of fatty acids, and biogenesis of mitochondria. We hypothesized that metabolic cardiomyopathy could occur in AL hens and act as a pathological cue in cardiac hypertrophic remodeling leading to overt cardiac dysfunction.
MATERIALS AND METHODS

Animal Management
A flock of Arbor Acres Plus Fast Feathering (FF) broiler breeder hens, 23 wk old with an average weight of 2.8 kg, was purchased from a local breeder farm. Hens were raised to age of 45 wk using breeder company recommendations for feed amounts to achieve a targeted body weight (3.6 kg) and to avoid rapid compensatory growth in frame size (skeletal and muscular growth) upon release from restricted feeding. Feed amounts were adjusted weekly to provide a nutritionally adequate soy-and corn-based breeder mash. All birds were maintained on a photoschedule 14L:10D (lights on at 05:00 AM) with feed provided at 08:30AM and free access to water throughout the experiment. At age 45 wk, 15 birds were continued per breeder recommended ration restrictions (restricted group, R) while another 15 birds were provided with sufficient feed for consumption to appetite (unrestricted group, ad libitum, AL). All bird husbandry, tissue collections, and bird numbers used for cardiac pathogenesis and survival feeding trial were conducted in accordance with an approved animal care protocol by the Institutional Animal Care and Use Committee (IACUC) of National Chung Hsing University, Taiwan.
Necropsy and Tissue Collection
At age 46 and 48 wk (7 d and 21 d after feeding treatment), tissues were collected from 3 and 12 hens, respectively, from each treatment group following an overnight fast. Prior to tissue collection, birds were physically restrained in dorsal recumbency and anesthesia was induced via face mask with isoflurane. Of the 12 hens studied at the age of 48 wks, 3 hens were used for immunostaining and histochemistry and 3 hens for in situ apoptosis analysis. The remaining 6 birds were used for biochemical and molecular analyses.
Histology, Fibrosis, Immunohistochemistry, in Situ Apoptosis and Caspase Activity Analysis
Paraffin embedded sections from below the ventricular midline were used for hematoxylin and eosin (H&E) staining to evaluate leukocyte infiltration, trichrome Masson staining to visualize tissue fibrosis (Histology Service of the National Chung Hsing University, Taiwan) , and for immunohistochemical staining to examine MHC-β staining with the antigen retrieval method as described previously (Liu et al., , 2016 . Sections were incubated with mouse antichicken MHC-β antibody (clone 2E9, Developmental Studies Hybridoma Bank, Iowa City, IA) 1:50 in blocking buffer for one h at 37
• C. After several washes, a secondary antibody (goat anti-mouse IgG conjugated with Alexa-488) was used for fluorescent visualization.
Terminal transferase dUTP nick end labeling (TUNEL) assay used de-waxed sections for in situ apoptosis analysis (Click-iT R Plus, Roche Applied Science, Indianapolis, IN). Three sections per hen and 5 images from each section were used for chromogenic or fluorescence intensity quantification using Image-J software (NIH, Bethesda, MD). Caspase-3/7 activity of protein extracts from freshly collected heart ventricles was determined as the cleavage rate of the fluorophoric peptide substrate (Caspase-Glo R 3/7 assay system, Promega, Madison, WI) according to the manufacturer's instructions using a microplate reader (Infinite F200 PRO, Tecan Group Ltd., Mannedorf, Switzerland) with excitation at 480 nm and emission at 520 nm. Assay values were expressed at counts per minute (CPM).
Determination of SOD, PDH Activity, and NO, GSH, GSSG, and MDA Content
Heart ventricles were collected, quickly cooled, minced, and portioned prior to homogenization in assay buffers. Tissue GSH (glutathione) and GSSG (oxidized GSH) content was measured in supernatants using commercial kits (Item # 703002 and 15491, respectively, Cayman Chemical Company, Ann Arbor, MI) exactly as instructed. Superoxide dismutase (SOD) activity was measured using a test kit (Item # 706002, Cayman Chemical Company, Ann Arbor, MI) with supernatants prepared by centrifugation at 700 × g for 5 min at 4
• C of a 10 % tissue homogenate (in 20 mM HEPES,one mM EGTA, 210 mM mannitol, and 70 mM sucrose, pH 7.2).
Cardiac glycolytic activity was analyzed as pyruvate dehydrogenase (PDH) activity using a colorimetric kit (Cat. # K679-100, BioVision, Inc., Milpitas, CA). Tissue malondialdehyde (MDA) content was measured in supernatants (at 1600 × g for 10 min at 4
• C) of 10 % tissue homogenates in RIPA buffer using a test kit (Item # 708070, Cayman).
Glucose, NEFA, Insulin, TG, Ceramide, DNA, and Protein Content Determination
Commercial kits were used to determine plasma glucose, triacylglycerol (TG), and non-esterified fatty acids (NEFA) (Wako, Osaka, Japan). Plasma insulin levels were determined by a validated commercial ELISA kit (Cat.# 10-1249-01, Uppsala, Sweden) (Franssens et al., 2015) . Separation and quantification of cardiac TG content was performed using published methods .
Ceramide content was determined by measuring fluorescence of products formed following alkaline hydrolysis exactly as described (He et al., 2005; Pan et al., 2012) . Cardiac protein content was determined by a colorimetric kit (Bradford assay kit, Bio-Rad, Hercules, CA).
Gene Expression by Real-time PCR Analysis
Freshly collected heart tissues were quickly dissected on ice into one mm3 pieces prior to placing into RNAlater TM (Invitrogen, Waltham, MA) , and stored at -80
• C until use. Total RNA extraction, random priming reverse transcription, and qRT-PCR amplification were conducted as described previously using commercial kits (Applied Biosystems, Waltham, MA). Information about the primers is given in Sup. Table S2 . Reactions were conducted in triplicate and the intra-assay coefficient of variation (CV) was less than 10 %.
Western Blot Analysis
Left ventricle homogenates were prepared in RIPA buffer and used for Western blot analysis as described . All primary antibodies were crossreactive to chicken antigens. A rabbit anti-chicken interleukin-1β (IL-1β, Cat. # ab-24771), IL-6 (Cat. # ab-24769), and anti-human GLUT-12 (glucose transporter-12, Cat# ab-1100993) and GLUT-2 (sc-9117) antibodies were purchased from Abcam (Cambridge, UK) and Santa Cruz (Dallas, TX), respectively. A horseradish peroxidase-conjugated secondary antibody (Cell Signaling Technology, Danvers, MA) was used to identify the bands reactive to the primary antibodies through an enhanced chemiluminescence reagent (Pierce Biotechnology Inc., Rockford, IL).
Statistics
Data from Western blot studies that were done once at 46 or 48 wk were analyzed by one-way ANOVA. Measurements made at multiple time points were analyzed by two-way ANOVA, in which feed intake manipulation (AL or R) and duration after feeding trial (7 d or 21 d) were the classifying variables. Differences between group means in Western blot studies were tested by student's t test, and others were tested using Bonferroni t test when the main effect was significant. If an interaction between feed intake and duration was found, a mean comparison was performed. Values were expressed as means ± SEM. Mean differences were considered significant at P < 0.05. All statistical procedures were carried out using SPSS for Windows 13.0.
RESULTS
Plasma insulin levels increased progressively in AL hens, and were 130% higher than that of R-hens at 21d in conjunction with higher plasma glucose and NEFA concentrations (P < 0.05, Table 2 ). Plasma TG levels decreased in AL hens over time (P < 0.05, Table 2 ). In contrast to 7 d, cardiac TG concentration of AL hens increased by 45% at 21 d and was 56% greater than that of R hens (P < 0.05, Figure 1 ; panel A). AL feeding promoted cardiac ceramide accumulation by 93% at 21 d (P < 0.05, Figure 1 ; panel C). Changes in AL hen cardiac lipid composition were accompanied by up-regulation of several lipid metabolizing genes, namely, DGAT-1 (diacylglycerol O-acyltransferase 1) Table 1 . Plasma insulin, glucose, non-esterified fatty acid, triacylglycerol, and ceramide concentration of broiler hens in response to restricted or unrestricted feeding. D) were normalized to β-actin (mRNA) and expressed as ratios relative to feed-restricted hens (R hens). Results were expressed as means ± SEM (n = 3 for 7 d, n = 6 for 21 d). R hen d 7 value is used as comparator. Means with different superscript letters within the same feeding period are significantly different (P < 0.05). * significant difference vs. treatment period for 7 d (P < 0.05). TG; triacylglycerol, ACC-1; acetyl-CoA carboxylase 1 or alpha (ACACA), DGAT-1; diacylglycerol O-acyltransferase 1, SMase; sphingomyelinase or sphingomyelin. Phosphodiesterase (SMPD), SPT; serine palmitoyltransferase or serine palmitoyltransferase, long chain base subunit 1 (SPTLC1).
at 7d, ACC-1 (acetyl-CoA carboxylase -1) and SMase (sphingomyelinase) at 7 d and 21 d, and SPT (serine palmitoyltransferase) at 21 d (P < 0.05, Figure 1 ; panels B and D).
AL-hen cardiac MDA content was 17% increased at 21 d despite a concomitant 23% increase in SOD activity relative to R hen values (P < 0.05, Table 2 ). Cardiac GSH reservoir decreased transiently in AL hens with 7 d tissue concentrations being 70% that of R hen values (P < 0.05, Table 2 ). Both groups had similar cardiac concentrations at 21 d that averaged 53% greater than 7 d R hen tissue GSH (P < 0.05). In AL hens cardiac GSSG concentration also increased at 21 d with 58% greater than 7 d values (P < 0.05) and so reducing 21 d GSH/GSSG in AL hens to 77% of R hen values (P < 0.05).
Cardiac glycolytic capacity as analyzed by PDH activity increased progressively in AL hens and was 90% higher than that of R hens at 21 d, whereas expression of CPT-1, the key regulator of β-oxidaton in AL hens decreased progressively, being 3.6-fold higher than that of R hens at 7 d but with no difference at 21 d (Figure 2 , Panels A and B). AL feeding also increased GLUT-2 and -12 at 21 d (Figure 2 , panel C) (P < 0.05). In accompaniment with lipotoxicity, AL feeding promoted cardiac inflammation as evidenced by increased leukocyte infiltration as well as IL-1β and IL-6 production at 21 d (P < 0.05, Figure 3) .
Analyses of in situ apoptosis by TUNEL assay showed that tissue labeling was about 60% greater in AL hens than R hens at 21 d (P < 0.05, Figure 4 ; panel A). Caspase-3/7 activity was also greater in AL hens (P < 0.05, Figure 4 ; Panel B). Pathological progression of cardiac change in AL hens was further demonstrated by fibrotic transformation and significantly higher intensity of MHC-β immunostaining of the left ventricle (P < 0.05, Figure 4 ; Panels C and D).
DISCUSSION
Cardiac pathological hypertrophy and overt pathogenesis in morphology and contractility were documented in the same hens used in the present study along with a 4-fold increase in mortality following 70 d (10 wk) of AL feeding consumption. In that study, hens showed higher systolic blood pressure and pathologic cardiac hypertrophy characterized by suppressed AMPK activation, which is an indicator of metabolic cardiomyopathy due to fuel overloading. As in the case of ovarian health (Chen et al., 2006; Pan et al., 2012; Xie et al., 2012; Liu et al., 2014 Liu et al., , 2016 , AL feed consumption increased cellular apoptosis and inflammation status within heart tissues in as few as 21 d, in conjunction with changes in cardiac bioactive lipid metabolism and oxidative stress. Similar to the pathogenesis of cardiac hypertrophy in rodent models, AL hens developed systemic diabetic-like conditions, interstitial fibrosis, while shifting from oxidative to glycolytic metabolism (an increasing PDH activity but decreasing CPT-1 expression) in association with increased MHC-β expression. All observed changes are considered hallmarks of heart failure (Catalucci et al., 2008; Maillet et al., 2013) . Nain et al. (2008) demonstrated that growing broilers diagnosed with congestive heart failure shift to a more glycolytic metabolism. The results suggest that AL feed consumption by adult broiler hens leads to cardiac hypertrophy in response to increased cardiac work caused by systemic hypertension, diabeticlike metabolism, cardiac inflammation, and lipotoxic cardiomyopathy that, in concert, dysregulate cardiac contractility, compromising heart function.
Pathogenesis of numerous metabolic diseases is linked to lipotoxicity (Cowart, 2011; Jiang et al., 2011) . Accumulation of myocardial ceramide was shown to induce cell apoptosis, impair cardiac contractility, and * ; significant difference vs. treatment period for 7 d (P < 0.05). PDH; pyruvate dehydrogenase, CPT-1; carnitine palmitoyltransferase 1, GLUT-2 and -12; glucose transporter 2 and 12.
provoke non-ischemic heart failure (Zhou et al., 2000; Cowart, 2011) . In large part, ceramide mediated impairment of Akt signaling is thought to underlie lipotoxicity (Cowart, 2011; Jiang et al., 2011) . Pharmacological inhibitors of ceramide synthesis are known Results of Western blot studies were normalized to β-actin form (protein) and expressed as ratios relative to feed-restricted hens (R hens). All results were expressed as means ± SEM (n = 3 for 7 d, n = 6 for 21 d). Panels B and C compare AL hen values to R hen values from matching test day. Means with different superscript letters within the same feeding period are significantly different (P < 0.05). IL-1β; interleukin 1β, IL-6; interleukin 6, R; restriction, AL; ad libitum. to relieve cardiomyopathies (Park et al., 2008; Cowart, 2011) . AL hens exhibited impaired cardiac fatty acid homeostasis despite transiently enhanced DAGT-1 and CPT-1 expression that might have served to dissipate excess fatty acids and so prevent lipotoxic progression. Enhanced β-oxidation, however, also may increase reactive oxygen species (ROS) leakage, leading to oxidative stress. Since the liver is the only organ responding to insulin signaling in chickens (Dupont et al., 2009) , up-regulation of cardiac GLUT-2 (the predominant GLUT in the chicken heart, Kono et al., 2005) and insulin-responsive GLUT-12 (birds lack GLUT-4, Coudert et al., 2015) , and increased ACC-1 activation and expression in concert with increases in plasma glucose and NEFA thus indicate a dramatic increase of fatty acid availability to drive lipotoxic progression and transient diabetes in cardiomyocytes. The changes may further accelerate the shift from oxidative toward more glycolytic activity independent of adult-type MHC replacement by neonatal MHC-β during pathological cardiac hypertrophy. Impaired fatty acid oxidation efficiency and metabolic flexibility in chickens genetically selected for rapid growth have been attributed to a higher PDH activity to accommodate acetyl-CoA influx from fatty acid oxidation (Zhang et al., 2014) . In obese individuals, diabetic cardiomyopathy develops with transient up-regulation of genes associated with β-oxidation due to peroxisome proliferator-activated receptor α (PPARα) and PPARγ coactivator 1-α (PGC-1α) activation to dissipate excessive fatty acids * significant difference vs. R hens. MHC-β; Myosin heavy chain, cardiac muscle beta. (Palomer et al., 2013) . Initially helpful, these changes finally impair mitochondrial functions, drive pathological cardiac hypertrophy, and may lead to ischemic heart diseases. In mammals, proinflammatory cytokines mediate cardiac hypertrophy, fibrosis, and apoptosis, contributing to ventricle dilation and chronic heart failure (Gullestad et al., 2012) . Moreover, mice with IL-6 gene knockout exhibited less severe cardiac fibrosis and leukocyte infiltration but still developed hypertension and cardiac hypertrophy in response to a high salt diet and angiotensin II (Gonzalez et al., 2015) , while sub-inflammatory concentrations of cardiac IL-1β constitutively increased IGF-1 production and sustained compensatory cardiac hypertrophy in mice with aortic banding (Honsho et al., 2009) . Several endocrine and local stimuli such as hyperglycemia, elevated plasma NEFA, lipoproteins, oxidative stress, angiotensin-II, endothelin-1, and cytokine themselves have been shown to induce proinflammatory cytokine production by activating the NF-κB pathway (Palomer et al., 2013) . In mouse cardiac hypertrophy, genomic analysis suggested that genes related to fibrosis and immune response exclusively respond to maladaptive stimuli in contrast to adaptive hypertrophy (Sheehy et al., 2009) .
Hepatic lipogenesis accounts for over 80% of fatty acids accumulated in the body of chickens (Griffin et al., 1992) . In laying hens, estrogen stimulation greatly enhances hepatic lipogenesis and production of TG-rich very low density lipoprotein (VLDL), being targeted to the ovary for yolk formation . Our earlier studies showed that upon release from longterm feed restriction, broiler hens exhibit granulosa cell death and resultant decline of plasma estrogen level and rapid ovarian regression (Chen et al., 2006; Pan et al., 2012; Xie et al., 2012; Liu et al., 2014 Liu et al., , 2016 . A decline in egg production suggests that accumulated plasma TG was no longer targeted for yolk deposition and thus became available to the heart, which prefers fatty acids as an energy source (Grynberg and Demaison, 1996) . This suggestion is supported by the findings in the same flock of hens, in which dramatic increases of relative heart weight in AL-hens at d 21, a time when no further increases in adipose weight were observed, but when egg production decreased by 25%. Others reported expression of the apolipoprotein B (apoB) gene in failing hearts (Nielsen et al., 1998) with TG-rich lipoprotein secretion as a possible cardioprotective mechanism in mammals. We examined this potential mechanism and were unable to demonstrate apoB expression in broiler hen hearts (data not shown).
This is the first report of molecular mechanisms by which excess energy intake by broiler hens first causes compensatory cardiac growth and remodeling that progress into pathogenesis, including inflammation, cardiac myocyte apoptosis, and interstitial fibrosis. The pathological hypertrophic remodeling is associated with systemic diabetic-like conditions and metabolic cardiomyopathies due to lipotoxic mechanisms.
